CN Stock MarketDetailed Quotes

Yili Chuanning Biotechnology (301301)

Watchlist
  • 10.46
  • +0.02+0.19%
Market Closed Apr 10 15:00 CST
23.33BMarket Cap30.32P/E (TTM)

Yili Chuanning Biotechnology (301301) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical intermediates4.15B89.92%
Other business389.55M8.44%
Other products75.71M1.64%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry4.23B91.56%
Other business389.55M8.44%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China1.87B40.53%
North China884.49M19.16%
Exit624.44M13.53%
South China490.59M10.63%
Northwest405.23M8.78%
Central China230.71M5.00%
Southwest86.77M1.88%
Northeast China23.3M0.50%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More